UK, US, Canada accuse Russia of hacking virus vaccine trials

Britain, the United States and Canada say Russia is trying to steal information from researchers seeking a COVID-19 vaccine.

News 12 Staff

Jul 16, 2020, 1:17 PM

Updated 1,541 days ago

Share:

UK, US, Canada accuse Russia of hacking virus vaccine trials
Britain, the United States and Canada say Russia is trying to steal information from researchers seeking a COVID-19 vaccine.

The three nations alleged Thursday that hacking group APT29, also known as Cozy Bear and said to be part of the Russian intelligence service, is attacking academic and pharmaceutical research institutions involved in coronavirus vaccine development.

The persistent and ongoing attacks are seen by intelligence officials as an effort to steal intellectual property, rather than to disrupt research.

Britain’s National Cybersecurity Centre made the announcement, which was coordinated with authorities in the U.S. and Canada.

It was unclear whether any information actually was stolen but the National Cypersecurity Centre says individuals’ confidential information is not believed to have been compromised.
MORE: President Trump hopeful to have COVID-19 vaccine on market by year's end 

Cozy Bear has been identified by Washington as one of two Russian government-linked hacking groups that broke into the Democratic National Committee computer network and stole emails ahead of the 2016 presidential election. The other group is usually called Fancy Bear.

It's also unclear whether Russian President Vladimir Putin knew about the vaccine research hacking, but British officials believe such intelligence would be highly prized.

U.S. authorities have for month leveled similar accusations against China. FBI Director Chris Wray said last week, “At this very moment, China is working to compromise American health care organizations, pharmaceutical companies, and academic institutions conducting essential COVID-19 research.”
undefined
 
By JILL LAWLESS and DANICA KIRKA
Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.